检索

期
标题
作者
卷 13, 编号 3 (2022)
Modern possibilities of intensive treatment of dyslipidemia and gaps in its control: literature review
Larina V., Golovko M., Larin V., Mironovna T., Orlov D.
PDF
(Rus)
卷 13, 编号 1 (2022)
Optimizing therapy for cardiovascular diseases: proven organ-protective and preventive effects of pitavastatin and lercanidipine: A review
Bubnova M.
PDF
(Rus)
卷 8, 编号 3 (2017)
Modern opportunities for lifestyle changes and statin therapy in the prevention of cardiovascular diseases
Bubnova M.
PDF
(Rus)
卷 1, 编号 1 (2010)
A real way of reducing coronary heart disease mortality in Russia
Aronov D., Bubnova M.
PDF
(Rus)
卷 12, 编号 2 (2021)
Statins in the primary prevention of cardiovascular disease. Rosuvastatin capabilities
Bubnova M., Ilchenko M., Lebedev P.
PDF
(Rus)
卷 8, 编号 2 (2017)
Treatment of atherogenic dyslipidemia: modern principles and new possibilities
Bubnova M.
PDF
(Rus)
卷 11, 编号 1 (2020)
Modern principles of atherogenic dyslipidemia management in special groups of patients
Bubnova M., Parnes L.
PDF
(Rus)
卷 7, 编号 3-4 (2016)
Acute coronary syndrome: pathogenesis, diagnosis, treatment, rehabilitation (Lecture 3)
Perepech N.
PDF
(Rus)
卷 11, 编号 2 (2020)
Statins and diabetes: focus on pitavastatin
Urazgildeeva S.
PDF
(Rus)
卷 6, 编号 1 (2015)
Statin therapy and atherosclerosis stabilization in carotid arteries
Luginova Z., Koshurnikova M., Solovieva E., Balakhonova T., Susekov A.
PDF
(Rus)
卷 10, 编号 1 (2019)
Adverse effects of statin therapy: real evidence
Bubnova M.
PDF
(Rus)
卷 5, 编号 3-4 (2014)
The increased risk of cardiovascular events in chronic kidney disease: pathogenetic mechanisms, the possibility of correction
Barysheva O., Melentieva A., Kheyfetz L., Balashov A.
PDF
(Rus)
卷 9, 编号 1 (2018)
Clinical efficacy of pitavastatin
Aronov D., Bubnova M.
PDF
(Rus)
卷 4, 编号 1 (2013)
Statins in the treatment and the prevention of the progression of atherosclerosis of patients with coronary heart disease
Morozova T., Vartanova O.
PDF
(Rus)
卷 8, 编号 4 (2017)
High-intensity therapy: rationale, indications and safety issues. Prospects of rosuvastatin in clinical practice
Bubnova M.
PDF
(Rus)
卷 4, 编号 2 (2013)
Pleiotropic effects of statins at the present stage of their study (focus on atorvastatin). Part III. Mechanisms of the pleiotropy of statins
Aronov D.
PDF
(Rus)
卷 8, 编号 3 (2017)
Impact of drug therapy on the risk of death in patients with coronary heart disease (according to the data of registry of cardiovascular diseases, RECVASA)
Pereverzeva K., Yakushin S., Vorobyev A., Lukyanov M., Andreyenko E., Zagrebelny A., Deev A.
PDF
(Rus)
卷 2, 编号 1 (2011)
Predoperatsionnaya terapiya statinamiu patsientov s ishemicheskoy bolezn'yu serdtsa
Barbarash O., Bayrakova Y., Kurguzova E.
PDF
(Rus)
1 - 18 的 18 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语

##common.cookie##